Alcon Gets FDA Approval for Travatan-Z Which Reduce Elevated Intraocular Pressure
Alcon Inc. (ACL) received Food and Drug Administration approval for Travatan Z for the reduction of elevated intraocular pressure in patients with glaucoma and ocular hypertension.
Travatan Z is a new formulation that eliminates benzalkonium chloride from Alcon's existing Travatan solution and replaces BAK with Sofzia, a robust ionic buffered preservative system that is gentle to the ocular surface, the eye-care company said.
Filed under Eye Treatment, Glaucoma
You may also like to read
- Lumigan, Allergan's Intraocular Pressure Drug, Received FDA Approval
- Phase II Clinical Trial of Mifepristone an Eye Drop Treatment for Steroid Associated Elevated Intraocular Pressure
- Timely Treatment Can Help To Cure Glaucoma
- Glaucoma Can Be Cured By Motogenol - A Natural Formula
- Trabectome Promises Better Treatment For Gloucoma Patients
- How to Protect Your Eye: 10-Point Eye Health Plan
- Princeton Eye Group Revolutionizes Cataract Surgery in Central New Jersey
- CustomVue Monovision Lasik Got Federal Approval
- Glaucoma Could Be Treated If Screened Earlier
- IntraLase Gets Approval to Sell Femtosecond Laser System in Taiwan
April 3rd, 2007 at 12:15 pm
I’m using since about 10 weeks Travatan Z to reduce ocular pressure on my left eye and after 8 days I noticed that my luxurius thick hair was getting thinner and was losing hair. Went to my dermatologist and had test where the keratin, sebum. estrogen etc .. were normal and my Internist suggested that if I was on Travatan Z, Sofzia the the ionic element causes 85% of the time loss of hair. He had some patients with the same problem that are/were on Travatan Z.
July 12th, 2007 at 10:14 am
Worst than that happened to my mother. It was presctiberd by Dr. Samer Ahmed who was with the Wilmer Institute until he was not reinstated again due to “problems” with patients.